BioCryst Pharmaceuticals (BCRX) to Present Three Posters on BCX4208 as Gout Treatment
Go back to BioCryst Pharmaceuticals (BCRX) to Present Three Posters on BCX4208 as Gout Treatment| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 8.98 -0.26 (2.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.24 | 52 Week High | $10.98 | |||
| Open | $9.17 | 52 Week Low | $1.63 | |||
| Day High | $9.25 | P/E | N/A | |||
| Day Low | $8.93 | EPS | $-0.68 | |||
| Volume | 2,929,186 | |||||
